REPORT ID 1807

Global Bioengineered Protein Drugs Market Research Report 2017

Publish Date
7-Dec-17
Pages
114
Format
Electronic (PDF)

In this report, the global Bioengineered Protein Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Bioengineered Protein Drugs in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Bioengineered Protein Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    GlaxoSmithKline
    Johnson & Johnson
    Merck
    Novartis
    Sanofi
    Eli Lilly
    F. Hoffmann-La Roche
    Dr. Reddy's Laboratories
    Abbott Laboratories
    Amgen
    Bayer AG
    Biocon
    Fresenius kabi
    Panacea Biotec
    ProBioGen AG
    Reliance Life Science
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Monoclonal Antibodies
    Therapeutic Proteins
    Vaccines
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Pharma and Biotech Companies
    CROs
    Academics

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Bioengineered Protein Drugs Market Research Report 2017
1 Bioengineered Protein Drugs Market Overview
    1.1 Product Overview and Scope of Bioengineered Protein Drugs
    1.2 Bioengineered Protein Drugs Segment by Type (Product Category)
        1.2.1 Global Bioengineered Protein Drugs Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Bioengineered Protein Drugs Production Market Share by Type (Product Category) in 2016
        1.2.3 Monoclonal Antibodies
        1.2.4 Therapeutic Proteins
        1.2.5 Vaccines
    1.3 Global Bioengineered Protein Drugs Segment by Application
        1.3.1 Bioengineered Protein Drugs Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Pharma and Biotech Companies
        1.3.3 CROs
        1.3.4 Academics
    1.4 Global Bioengineered Protein Drugs Market by Region (2012-2022)
        1.4.1 Global Bioengineered Protein Drugs Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Bioengineered Protein Drugs (2012-2022)
        1.5.1 Global Bioengineered Protein Drugs Revenue Status and Outlook (2012-2022)
        1.5.2 Global Bioengineered Protein Drugs Capacity, Production Status and Outlook (2012-2022)

2 Global Bioengineered Protein Drugs Market Competition by Manufacturers
    2.1 Global Bioengineered Protein Drugs Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Bioengineered Protein Drugs Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Bioengineered Protein Drugs Production and Share by Manufacturers (2012-2017)
    2.2 Global Bioengineered Protein Drugs Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Bioengineered Protein Drugs Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Bioengineered Protein Drugs Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Bioengineered Protein Drugs Market Competitive Situation and Trends
        2.5.1 Bioengineered Protein Drugs Market Concentration Rate
        2.5.2 Bioengineered Protein Drugs Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Bioengineered Protein Drugs Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Bioengineered Protein Drugs Capacity and Market Share by Region (2012-2017)
    3.2 Global Bioengineered Protein Drugs Production and Market Share by Region (2012-2017)
    3.3 Global Bioengineered Protein Drugs Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Bioengineered Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Bioengineered Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Bioengineered Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Bioengineered Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Bioengineered Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Bioengineered Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Bioengineered Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Bioengineered Protein Drugs Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Bioengineered Protein Drugs Consumption by Region (2012-2017)
    4.2 North America Bioengineered Protein Drugs Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Bioengineered Protein Drugs Production, Consumption, Export, Import (2012-2017)
    4.4 China Bioengineered Protein Drugs Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Bioengineered Protein Drugs Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Bioengineered Protein Drugs Production, Consumption, Export, Import (2012-2017)
    4.7 India Bioengineered Protein Drugs Production, Consumption, Export, Import (2012-2017)

5 Global Bioengineered Protein Drugs Production, Revenue (Value), Price Trend by Type
    5.1 Global Bioengineered Protein Drugs Production and Market Share by Type (2012-2017)
    5.2 Global Bioengineered Protein Drugs Revenue and Market Share by Type (2012-2017)
    5.3 Global Bioengineered Protein Drugs Price by Type (2012-2017)
    5.4 Global Bioengineered Protein Drugs Production Growth by Type (2012-2017)

6 Global Bioengineered Protein Drugs Market Analysis by Application
    6.1 Global Bioengineered Protein Drugs Consumption and Market Share by Application (2012-2017)
    6.2 Global Bioengineered Protein Drugs Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Bioengineered Protein Drugs Manufacturers Profiles/Analysis
    7.1 GlaxoSmithKline
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Bioengineered Protein Drugs Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 GlaxoSmithKline Bioengineered Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Johnson & Johnson
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Bioengineered Protein Drugs Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Johnson & Johnson Bioengineered Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Merck
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Bioengineered Protein Drugs Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Merck Bioengineered Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Novartis
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Bioengineered Protein Drugs Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Novartis Bioengineered Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Sanofi
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Bioengineered Protein Drugs Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Sanofi Bioengineered Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Eli Lilly
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Bioengineered Protein Drugs Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Eli Lilly Bioengineered Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 F. Hoffmann-La Roche
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Bioengineered Protein Drugs Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 F. Hoffmann-La Roche Bioengineered Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Dr. Reddy's Laboratories
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Bioengineered Protein Drugs Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Dr. Reddy's Laboratories Bioengineered Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Abbott Laboratories
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Bioengineered Protein Drugs Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Abbott Laboratories Bioengineered Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Amgen
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Bioengineered Protein Drugs Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Amgen Bioengineered Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 Bayer AG
    7.12 Biocon
    7.13 Fresenius kabi
    7.14 Panacea Biotec
    7.15 ProBioGen AG
    7.16 Reliance Life Science

8 Bioengineered Protein Drugs Manufacturing Cost Analysis
    8.1 Bioengineered Protein Drugs Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Bioengineered Protein Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Bioengineered Protein Drugs Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Bioengineered Protein Drugs Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Bioengineered Protein Drugs Market Forecast (2017-2022)
    12.1 Global Bioengineered Protein Drugs Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Bioengineered Protein Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Bioengineered Protein Drugs Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Bioengineered Protein Drugs Price and Trend Forecast (2017-2022)
    12.2 Global Bioengineered Protein Drugs Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Bioengineered Protein Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Bioengineered Protein Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Bioengineered Protein Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Bioengineered Protein Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Bioengineered Protein Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Bioengineered Protein Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Bioengineered Protein Drugs Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Bioengineered Protein Drugs Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer